A disposable set for a peritoneal dialysis (“PD”) treatment includes a fresh PD fluid pumping portion; a used PD fluid pumping portion; a reusable tubing section including the fresh PD fluid pumping portion and a one-way valve, the reusable tubing section terminating at a first connector; and a disposable tubing section including the used PD fluid pumping portion and terminating at a second connector, the second connector configured to be connected to the first connector to form the disposable set for use in the PD treatment.
A peritoneal dialysis (“PD”) system includes a disposable set including a pump chamber having a flexible sheet, one side of the flexible sheet positioned and arranged during operation to receive pneumatic pressure; and a cycler including at least one source of positive and negative pneumatic pressure for delivering pneumatic pressure to the pump chamber, an air flow sensor, a pneumatic pressure sensor, a temperature sensor, a plurality of fluid valves, and a control unit configured to integrate outputs from the air flow sensor, the pneumatic pressure sensor and the temperature sensor over time to determine an amount of fresh or used PD fluid discharged from the pump chamber under positive pneumatic pressure and via an open one of the plurality of fluid valves.
Ultrafiltration (UF) is monitored in a weight-based system for extracorporeal blood treatment. The system comprises a container holding a fluid that is pumped to or from a dialyzer by a pump. The container is intermittently refilled or drained by an adjustment arrangement during a level adjustment period (LAP). A scale measures the weight of the container. A monitoring device is operated to determine, before and after the LAP while the adjustment arrangement is deactivated and the pump is operated at a known setting, first and second values of a parameter of the pump based on a weight signal from the scale. The parameter may be flow rate or stroke volume. The monitoring device estimates a time profile for the parameter during the LAP based on the first and second values and determines the UF parameter based on the time profile.
A flexible plug for a medical fluid comprises a sealing member including a flexible cylindrical section that extends to a head; a rigid member holder secured to the sealing member; and a rigid sealing cap including a wall defining an opening, the head of the sealing member sealed within the opening to prevent the flow of medical fluid through the flexible plug. The flexible plug is sealed, e.g., solvent bonded, within a port tube, sleeve port or a Y-connector to form a flexible plug assembly. The user grasps and twists or torques the rigid member holder and the rigid sealing cap through the port tube, sleeve port or a Y-connector to unseal the head from the opening to allow the flow of medical fluid through the flexible plug. A method of manufacturing the flexible plug and associated assembly is also disclosed.
Methods, systems, and apparatuses for integrating medical device data are disclosed. In an example embodiment, an integration engine receives infusion therapy progress data from an infusion pump related to a patient identifier and receives renal failure therapy progress data from a renal failure therapy machine related to the same patient identifier. The integration engine determines fluid balance data based on a difference between at least some of the infusion therapy progress data and at least some of the renal failure therapy progress data and causes a combination user interface to display a trend of the fluid balance data within a fluid balance timeline. The integration engine determines when the trend of the fluid balance data exceeds a fluid balance limit and causes a fluid balance alarm or alert to be provided.
A61M 5/172 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte électriques ou électroniques
G16H 20/40 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des thérapies mécaniques, la radiothérapie ou des thérapies invasives, p. ex. la chirurgie, la thérapie laser, la dialyse ou l’acuponcture
G16H 40/67 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement à distance
H04L 67/12 - Protocoles spécialement adaptés aux environnements propriétaires ou de mise en réseau pour un usage spécial, p. ex. les réseaux médicaux, les réseaux de capteurs, les réseaux dans les véhicules ou les réseaux de mesure à distance
H04L 67/56 - Approvisionnement des services mandataires
A peritoneal dialysis (“PD”) system (10) including a PD machine (20); a patient line (50) extending from the PD machine (20); and a filter set (100) in fluid communication with the patient line (50), the filter set (100) including a filter body (110, 150, 190) housing first and second filter membranes (112a, 112b, such as a sterilizing grade or bacteria reduction filter membranes), the filter body (110, 150, 190) configured to be placed in different arrangements such that fresh PD fluid (i) flows through the first filter membrane (112a) and then through the second filter membrane (112b) or (ii) splits and flows through first and second filter membranes (112a, 112b) in parallel.
A peritoneal dialysis (“PD”) system (10) includes a PD machine (20); a patient line (50) extending from the PD machine (20); and a filter set (100) in fluid communication with the patient line (50), the filter set (100) including a filter membrane (120, such as a sterilizing grade or a bacteria reduction filter membrane) positioned and arranged such that fresh PD fluid flows through the filter membrane (120) into a filtered fluid compartment (106f), wherein the filtered fluid compartment (106f) includes an outlet (106t) to a port (106p), and wherein the port (106p) is in fluid communication with a used PD fluid tube (106u) positioned and arranged to carry used PD fluid past the filter membrane (120) without contacting the filter membrane (120). A method for priming filter set (100) is also disclosed.
A peritoneal dialysis system includes a control unit configured to (i) store a sleep state pattern for the patient, (ii) begin a patient drain followed by a patient fill when at least one sensor indicates that the patient is in a deep sleep state, (iii) extend a dwell period if the sleep state pattern indicates that the patient will enter a subsequent deep sleep state within a first time duration after a programmed dwell period, and (iv) shorten the dwell period if the sleep state pattern indicates that the patient will leave the deep sleep state within a second time duration after an end of the programmed dwell period. The system alternatively or additionally assesses or records a stress level of and/or a fluid/caloric intake by the patient and takes actions accordingly.
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/16 - Dispositifs pour la psychotechnieTest des temps de réaction
G16H 20/17 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients administrés par perfusion ou injection
10.
PERITONEAL DIALYSIS SYSTEM HAVING A PATIENT LINE FILTER
A peritoneal dialysis (“PD”) system (10) includes a PD machine (20); a patient line (50) extending from the PD machine (20); and a filter set (100) in fluid communication with the patient line (50), the filter set (100) including a filter membrane (120, e.g., a sterilizing grade filter membrane or a bacteria reduction filter membrane) positioned and arranged such that fresh PD fluid flows through the filter membrane (120) into a filtered fluid compartment (106f), wherein the filtered fluid compartment (106f) includes an outlet (1060) to a port (106p), and wherein the port (106p) is in fluid communication with a circumferential used PD fluid channel (106c) positioned and arranged to carry used PD fluid around the filter membrane (120) without contacting the filter membrane (120). A method for priming filter set (100) is also disclosed.
The present disclosure relates to improved lipid emulsions for providing parenteral nutrition, including ready-to-use parenteral nutrition formulations comprising such lipid emulsions. More particularly, the present disclosure is directed to improved lipid formulations or emulsions including multi-chamber containers comprising same, wherein the lipid emulsion contains DHA, EPA, and ARA in an optimized concentration and ratio, optionally in combination with choline and defined levels of phytosterols. The present disclosure further relates to methods of avoiding and/or treating liver damage and/or inflammation, and to methods for improving fatty acid profiles in plasma and certain tissues or organs especially of pediatric patients.
A61K 31/202 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p. ex. acides stéarique, palmitique ou arachidique ayant au moins trois doubles liaisons, p. ex. acide linolénique
A23L 33/00 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement
A23L 33/10 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs
A23L 33/11 - Stérols de plantes ou leurs dérivés, p. ex. phytostérols
A23L 33/115 - Acides gras ou leurs dérivésGraisses ou huiles
A23D 7/00 - Compositions à base d'huiles ou de graisses comestibles contenant une phase aqueuse, p. ex. margarines
A23D 7/005 - Compositions à base d'huiles ou de graisses comestibles contenant une phase aqueuse, p. ex. margarines caractérisées par des ingrédients autres que des triglycérides d'acides gras
A23D 7/01 - Autres esters d'acides gras, p. ex. phosphatides
12.
PERITONEAL DIALYSIS SYSTEM HAVING A CAPILLARY PATIENT LINE FILTER
A peritoneal dialysis (“PD”) system (10) includes a PD machine (20); a patient line (50) (which may be a dual lumen patient line) extending from the PD machine (20); a filter set (100) in fluid communication with the patient line (50), the filter set (100) including a plurality of hollow fiber membranes (120, e.g., sterilizing grade or bacteria reduction hollow fiber membranes) positioned and arranged such that fresh PD fluid flows through porous walls of the hollow fiber membranes (120) prior to exiting the filter set (100).
A peritoneal dialysis (“PD”) system (10) includes a PD machine (20); a patient line (50) extending from the PD machine (20); and a filter set (100) including a filter housing (102) having a tubular filter membrane (120, such as a sterilizing grade or bacteria reduction filter membrane) positioned and arranged to filter fresh PD fluid flowing radially across the tubular filter membrane (120), and a transfer set-side port (106p) positioned and arranged to receive (i) filtered fresh PD fluid during a patient fill and (ii) used PD fluid during a patient drain.
A peritoneal dialysis (“PD”) system (10) includes a PD machine (20); a patient line (50) extending from the PD machine (20); and a filter set (100) including a filter housing (102) having an upper housing plate (102u) and a lower housing plate (102l), and a filter membrane (112, such as a sterilizing grade or a bacteria reduction filter membrane) located between the upper housing plate (102u) and the lower housing plate (102l), the filter set (100) further including a lumen-side connector (104) configured to connect to the patient line (50), the lumen-side connector (104) connected to the filter housing (102) via at least one of a fresh PD fluid tube (106a) or a used PD fluid tube (106b). A method for manufacturing the filter set (100) is also disclosed.
The present disclosure relates to improved lipid emulsions for providing parenteral nutrition, including ready-to-use parenteral nutrition formulations comprising such lipid emulsions. More particularly, the present disclosure is directed to improved lipid formulations or emulsions including multi-chamber containers comprising same, wherein the lipid emulsion contains DHA, EPA, and ARA in an optimized concentration and ratio, optionally in combination with choline and defined levels of phytosterols. The present disclosure further relates to methods of avoiding and/or treating liver damage and/or inflammation, and to methods for improving fatty acid profiles in plasma and certain tissues or organs especially of pediatric patients.
A61J 7/00 - Dispositifs pour administrer les médicaments par voie buccale, p. ex. cuillèresDispositifs pour compter les pilulesDispositions pour l'indication ou le rappel du moment où l'on doit prendre des médicaments
A61K 31/14 - Composés d'ammonium quaternaire, p. ex. édrophonium, choline
A61K 31/202 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p. ex. acides stéarique, palmitique ou arachidique ayant au moins trois doubles liaisons, p. ex. acide linolénique
A61K 31/685 - Diesters d'acide du phosphore avec deux composés hydroxyle, p. ex. phosphatidylinositols un des composés hydroxylés ayant des atomes d'azote, p. ex. phosphatidylsérine, lécithine
A61K 45/06 - Mélanges d'ingrédients actifs sans caractérisation chimique, p. ex. composés antiphlogistiques et pour le cœur
A61P 3/02 - Nutriments, p. ex. vitamines, minéraux
A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]
The present disclosure relates to improved lipid emulsions for providing parenteral nutrition, including ready-to-use parenteral nutrition formulations comprising such lipid emulsions. More particularly, the present disclosure is directed to improved lipid formulations or emulsions including multi-chamber containers comprising same, wherein the lipid emulsion contains DHA, EPA, and ARA in an optimized concentration and ratio, optionally in combination with choline and defined levels of phytosterols. The present disclosure further relates to methods of avoiding and/or treating liver damage and/or inflammation, and to methods for improving fatty acid profiles in plasma and certain tissues or organs especially of pediatric patients.
A61K 31/202 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p. ex. acides stéarique, palmitique ou arachidique ayant au moins trois doubles liaisons, p. ex. acide linolénique
A61K 31/575 - Composés contenant des systèmes cycliques du cyclopenta[a]hydrophénanthrèneLeurs dérivés, p. ex. stéroïdes substitués en position 17 bêta par une chaîne d'au moins trois atomes de carbone, p. ex. cholane, cholestane, ergostérol, sitostérol
A61K 31/683 - Diesters d'acide du phosphore avec deux composés hydroxyle, p. ex. phosphatidylinositols
A61K 47/44 - Huiles, graisses ou cires couvertes par plus d’un des groupes Huiles, graisses ou cires naturelles ou naturelles modifiées, p. ex. huile de ricin, huile de ricin polyéthoxylée, cire de lignite, lignite, gomme-laque, colophane, cire d’abeille ou lanoline
A61P 1/16 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des troubles de la vésicule biliaire ou du foie, p. ex. protecteurs hépatiques, cholagogues, cholélitholytiques
A61P 3/02 - Nutriments, p. ex. vitamines, minéraux
A peritoneal dialysis (“PD”) machine includes a fresh/regenerated PD fluid pump, a used PD fluid pump, a sorbent cartridge located fluidically between the fresh/regenerated PD fluid pump and the used P fluid pump, a degassing tank located fluidically downstream from the sorbent cartridge, at least one valve located fluidically upstream of the degassing tank, and a control unit configured to control the fresh/regenerated PD fluid pump and the used PD fluid pump, the control unit further figured to operate the at least one valve to select whether fresh PD fluid or regenerated PD fluid is pumped by the fresh/regenerated PD fluid pump to the degassing tank.
A peritoneal dialysis (“PD”) system includes a PD fluid pump, a PD fluid heater positioned and arranged to heat fresh PD fluid pumped by the PD fluid pump, and a phase change material (“PCM”) device positioned and arranged to receive fresh PD fluid heated by the PD fluid heater. The PCM device includes a PCM having a melting temperature selected so that the PCM solidifies when underheated fresh PD fluid contacts the PCM transferring heat to the underheated fresh PD fluid. Alternatively or additionally, the PD system may include a different PCM device having a PCM with a melting temperature selected so that the PCM melts when overheated fresh PD fluid contacts the PCM thereby removing heat from the overheated fresh PD fluid. A configuration for the PCM device is also disclosed.
A system and method for self-aligning and connecting a device to a modular rack. The system includes a device comprising a connector receptacle configured to receive a connector plug and a bracket fixed to the device, a modular rack comprising the connector plug and a shelf configured to receive the bracket and guide the shelf in a plurality of directions. When the bracket of the device is inserted into the shelf of the modular rack, the shelf travels in the plurality of directions to self-align the connector plug of the modular rack to the connector receptacle of the device to ensure engagement of the connector plug to the connector receptacle.
H01R 13/631 - Moyens additionnels pour faciliter l'engagement ou la séparation des pièces de couplage, p. ex. moyens pour aligner ou guider, leviers, pression de gaz pour l'engagement uniquement
A61M 5/142 - Perfusion sous pression, p. ex. utilisant des pompes
F16L 37/00 - Accouplements du type à action rapide
H01R 13/52 - Boîtiers protégés contre la poussière, les projections, les éclaboussures, l'eau ou les flammes
H01R 13/73 - Moyens de montage des pièces de couplage sur les appareils ou structures, p. ex. sur un mur
H01R 43/26 - Appareils ou procédés spécialement adaptés à la fabrication, l'assemblage, l'entretien ou la réparation de connecteurs de lignes ou de collecteurs de courant ou pour relier les conducteurs électriques pour engager ou séparer les deux pièces d'un dispositif de couplage
20.
DAPTOMYCIN FORMULATIONS CONTAINING A COMBINATION OF SORBITOL AND MANNITOL
In an aspect, a method of manufacture of a pharmaceutically acceptable solid composition containing daptomycin includes drying an aqueous solution containing (i) water, (ii) the daptomycin, (iii) sorbitol in an amount of about 1.2 wt. % to about 9.0 wt. % of total volume of the aqueous composition and (iv) mannitol in an amount of about 0.6 wt. % to about 9.5 wt. % of total volume of the aqueous composition to form the solid composition. The drying can include a sublimation drying of about −25° C. to about 50° C. for a time period of about 15 hours to about 120 hours, most preferably about 15° C. for about 20 hours, optionally preceded and/or followed by one or more additional drying steps. Other aspects are the solid composition containing the daptomycin and also methods of treating a bacterial infection including administering a pharmaceutically acceptable product made by reconstituting the solid composition.
A61K 47/26 - Hydrates de carbone, p. ex. polyols ou sucres alcoolisés, sucres aminés, acides nucléiques, mono-, di- ou oligosaccharidesLeurs dérivés, p. ex. polysorbates, esters d’acide gras de sorbitan ou glycyrrhizine
21.
CONFIGURING AN ARRANGEMENT TO GENERATE TREATMENT FLUID FOR RENAL REPLACEMENT THERAPY
A system comprises a fluid generation arrangement (FGA), a user interface (UI), and a control unit. The FGA is operable to mix one or more concentrates with water to generate a treatment fluid for use in renal replacement therapy. The control unit is connected to the UI and arranged to configure the FGA by a computer-implemented method. In the method, the control unit receives, from the UI, a candidate set value of a selected component of the treatment fluid, calculates, for the candidate set value, a calculated composition of the treatment fluid, and displays, on the UI, a respective concentration value of one or more components other than the selected component in the calculated composition. By the system, a caretaker is made aware of consequential changes in the composition of the treatment fluid, in addition the selected component.
A dialysis fluid production system includes a water purification unit, at least one concentrate, a dialysis machine, a product container, and a recirculation container. The dialysis machine is configured to receive purified water from the water purification unit and to mix the purified water with the at least one concentrate to form dialysis fluid. The product container is positioned and arranged to receive the dialysis fluid from the dialysis machine, and the recirculation container is configured to receive an end of the drain line and an end of the dialysis fluid return line. Further, the recirculation container enables dialysis fluid to be recirculated from the drain line, through the dialysis fluid return line, back to the dialysis machine and is configured to be positioned adjacent to a facility drain such that overflow dialysis fluid flows from the recirculation container into the facility drain.
A drainage plate, a tray and a system for moist heat sterilization are provided. The drainage plate has a plurality of apertures sized to allow the fluid to pass through and includes a first region having a first aperture ratio; a second region having a second aperture ratio; and a third region having a third aperture ratio. The first region, the second region and the third region are sequentially arranged in a widthwise direction of the drainage plate, and the second aperture ratio is greater than the first aperture ratio and the third aperture ratio.
A61L 2/04 - Procédés ou appareils de désinfection ou de stérilisation de matériaux ou d'objets autres que les denrées alimentaires ou les lentilles de contactAccessoires à cet effet utilisant des phénomènes physiques de la chaleur
A23L 3/00 - Conservation des aliments ou produits alimentaires, en général, p.ex. pasteurisation ou stérilisation, spécialement adaptée aux aliments ou produits alimentaires
A61L 2/07 - Procédés ou appareils de désinfection ou de stérilisation de matériaux ou d'objets autres que les denrées alimentaires ou les lentilles de contactAccessoires à cet effet utilisant des phénomènes physiques de la chaleur des gaz chauds de la vapeur
24.
AUTOMATED PERITONEAL DIALYSIS CYCLER HAVING GRAVIMETRIC CONTROL
A peritoneal dialysis (“PD”) system includes a cycler having a weigh scale, a chamber for weighing by the weigh scale, a heater, a plurality of valves, a pump, and a control unit operable with the weigh scale, the heater, the plurality of valves and the pump; and a disposable set including a PD fluid container fitting within the chamber for weighing and heating, a supply line in fluid communication with the PD fluid container, a drain container fitting within the chamber for weighing, a drain line in fluid communication with the drain container, and a patient line positioned on an opposing side of the pump from the supply line and the drain lines, wherein the control unit is configured to operate the plurality of valves and the pump to pump used dialysis fluid to the drain container and fresh dialysis fluid from the PD fluid container.
The present disclosure relates to parenteral nutritional formulations, including ready-to-use parenteral nutrition formulations. More particularly, the present disclosure is directed to lipid formulations or emulsions and multi-chamber containers comprising same, wherein the lipid emulsion contains glycerophosphorylcholine as a choline source. The present disclosure further relates to methods of providing choline to a patient in need of parenteral nutrition and methods of avoiding and/or treating choline deficiency and liver damage.
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
A23D 7/005 - Compositions à base d'huiles ou de graisses comestibles contenant une phase aqueuse, p. ex. margarines caractérisées par des ingrédients autres que des triglycérides d'acides gras
A23D 7/01 - Autres esters d'acides gras, p. ex. phosphatides
A23L 33/125 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sirops d'hydrate de carboneModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sucresModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des alcools de sucreModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
A61J 1/20 - Dispositions pour le transfert des liquides, p. ex. du flacon à la seringue
A61J 3/00 - Dispositifs ou procédés spécialement conçus pour donner à des produits pharmaceutiques une forme physique déterminée ou une forme propre à leur administration
A61K 31/14 - Composés d'ammonium quaternaire, p. ex. édrophonium, choline
A61K 31/202 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p. ex. acides stéarique, palmitique ou arachidique ayant au moins trois doubles liaisons, p. ex. acide linolénique
A61K 31/232 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine d'acides ayant un groupe carboxyle lié à une chaîne d'au moins sept atomes de carbone ayant au moins trois doubles liaisons, p. ex. étrétinate
A61K 31/661 - Acides du phosphore ou leurs esters n'ayant pas de liaison P-C, p. ex. fosfosal, dichlorvos, malathion
A61K 31/685 - Diesters d'acide du phosphore avec deux composés hydroxyle, p. ex. phosphatidylinositols un des composés hydroxylés ayant des atomes d'azote, p. ex. phosphatidylsérine, lécithine
A61K 36/05 - Chlorophycota ou chlorophyta (algues vertes), p. ex. Chlorella
A61K 47/10 - AlcoolsPhénolsLeurs sels, p. ex. glycérolPolyéthylène glycols [PEG]PoloxamèresAlkyléthers de PEG/POE
A system and method are disclosed for detecting remaining battery voltage or capacity in an infusion device and generating alarms based on the detection. A battery lifetime extension method includes providing an infusion device that derives its power from a rechargeable battery. The infusion device may derive its power from a rechargeable battery. Furthermore, the infusion device receives, at predetermined intervals of time in real-time sensor data comprising a voltage, a change in the voltage over the predetermined interval of time, an average current, a temperature, and a remaining voltage or capacity reported by a battery gas gauge integrated circuit (“IC”) associated with the rechargeable battery. A customized neural network model utilizes the sensor data to determine an indicia of the actual remaining voltage or capacity of the rechargeable battery in real-time. The indicia may be used to lengthen and/or abate ongoing medical infusion therapy.
A61M 5/172 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte électriques ou électroniques
G01R 31/36 - Dispositions pour le test, la mesure ou la surveillance de l’état électrique d’accumulateurs ou de batteries, p. ex. de la capacité ou de l’état de charge
G01R 31/367 - Logiciels à cet effet, p. ex. pour le test des batteries en utilisant une modélisation ou des tables de correspondance
G01R 31/3842 - Dispositions pour la surveillance de variables des batteries ou des accumulateurs, p. ex. état de charge combinant des mesures de tension et de courant
H01M 10/48 - Accumulateurs combinés à des dispositions pour mesurer, tester ou indiquer l'état des éléments, p. ex. le niveau ou la densité de l'électrolyte
H02J 7/00 - Circuits pour la charge ou la dépolarisation des batteries ou pour alimenter des charges par des batteries
H04L 67/12 - Protocoles spécialement adaptés aux environnements propriétaires ou de mise en réseau pour un usage spécial, p. ex. les réseaux médicaux, les réseaux de capteurs, les réseaux dans les véhicules ou les réseaux de mesure à distance
A peritoneal dialysis (“PD”) system includes a housing and a dialysis fluid pump housed by the housing. The dialysis fluid pump includes a reusable pump body that accepts PD fluid for pumping and a flush flow port. The PD system also includes a dialysis fluid heater for heating PD fluid, a container configured to accept and hold PD fluid, a condenser in fluid communication with the container, a chamber in fluid communication with the condenser and a flush flow line extending from the chamber to the flush flow port. The PD system further includes a control unit programmed to cause the dialysis fluid heater to heat PD fluid in the container to form steam or water vapor. The steam or water vapor is condensed in the condenser into distilled water collected in the chamber and provided from the chamber to the flush flow port via the flush flow line.
A01K 89/01 - Moulinets pour la pêche à la ligne à enrouleur de fil "pick-up", c.-à-d. avec l'élément de guidage du fil tournant et la bobine fixe pendant la récupération normale du fil
A01K 89/015 - Moulinets pour la pêche à la ligne à tambour tournant
A61G 15/18 - Dispositifs de stockage, de maintien ou de transport pour pièces à main dentaires ou similaires comprenant des moyens de rappel pour ranger un tuyau flexible
A medical fluid container preparation system includes: a conveyor for conveying the medical fluid container; a water injector located along the conveyor; a mechanism for carrying the water injector towards and away from the medical fluid container; a sensor positioned and arranged to determine a location of the medical fluid container moving along the conveyor; and a control unit configured to read an output from the sensor and to cause (i) the mechanism to move the water injector towards the medical fluid container an amount based upon the location of the medical fluid container obtained from the sensor output and (ii) the water injector to inject a volume of water between the medical fluid container and an overpouch into which the medical fluid container is placed.
B65B 3/00 - Emballage de matériaux plastiques, de semi-liquides, de liquides ou de liquides et solides mélangés, dans des réceptacles ou récipients individuels, p. ex. dans des sacs ou sachets, boîtes, cartons, bidons ou pots
B65B 31/04 - Mise sous vide, sous pression ou sous gaz spécial, des réceptacles ou emballages pleins, au moyen d'ajutages par lesquels on envoie ou on retire de l'air ou d'autres gaz, p. ex. un gaz inerte
B65B 51/10 - Application ou production de chaleur ou de pression ou les deux à la fois
B65B 57/14 - Dispositifs de commande automatique, de vérification, d'alarme ou de sécurité sensibles à l'absence, à la présence, à l'alimentation anormale ou au mauvais positionnement des objets ou matériaux à emballer et dont le fonctionnement commande ou arrête l'alimentation des objets ou matériaux à emballer
B65B 57/16 - Dispositifs de commande automatique, de vérification, d'alarme ou de sécurité sensibles à l'absence, à la présence, à l'alimentation anormale ou au mauvais positionnement des objets ou matériaux à emballer et fonctionnant pour arrêter ou commander la vitesse de la machine entière
A61J 1/20 - Dispositions pour le transfert des liquides, p. ex. du flacon à la seringue
32.
SYSTEMS AND METHODS FOR DIALYSIS FLUID PREPARATION IN BATCH DISPOSABLE
A peritoneal dialysis system includes a water purifier; a disposable set including a water line in fluid communication with the water purifier, a drain line for draining from the disposable set, and a disposable container including at least one chamber, the disposable container including at least one concentrate in one of the at least one chamber, and the disposable container positioned and arranged to hold a dialysis fluid prepared by mixing water from the water purifier and the at least one concentrate; and a control unit in communication with at least one sensor, for detecting a first property of water from the water purifier and a second property of the dialysis fluid.
A61B 17/00 - Instruments, dispositifs ou procédés chirurgicaux
A61B 90/98 - Moyens d’identification pour les patients ou les instruments, p. ex. étiquettes utilisant des moyens électromagnétiques, p. ex. transpondeurs
34.
SYSTEM FEATURING OPTICAL AND ELECTRICAL SENSORS FOR CHARACTERIZING EFFLUENT FROM A PERITONEAL DIALYSIS PATIENT
The invention provides a system for characterizing an effluent sample from a patient undergoing peritoneal dialysis. The system features a container for enclosing the effluent sample, and optical system, an electrical system, and a processor. The optical system features a light source and a photodetector, the light source emitting a beam of radiation that passes through the container and irradiates the effluent sample, and the photodetector detecting the radiation after it irradiates the effluent sample to generate an optical signal. The electrical system typically features a first pair of electrodes and a second pair electrodes, both attached directly to the container and arranged to measure a capacitance of the effluent sample to generate a capacitance signal. The processor operates an algorithm that collectively processes the optical and capacitance signals to characterize the effluent sample.
A system is provided for characterizing an effluent sample from a patient undergoing peritoneal dialysis. The system features a container (30) for enclosing the effluent sample, an optical system, an electrical system, and a processor (13). The optical system features a light source (18, 24) and a photodetector (14, 54), the light source emitting a beam of radiation that passes through the container and irradiates the effluent sample, and the photodetector detecting the radiation after it irradiates the effluent sample to generate an optical signal. The electrical system features at least one pair of electrodes (38a, 38b) attached to the container and arranged to measure an electrical property of the effluent sample to generate a property signal. The processor operates an algorithm that collectively processes the optical and property signals to characterize the effluent sample.
09 - Appareils et instruments scientifiques et électriques
Produits et services
Downloadable medical software for receiving, storing,
displaying and transmitting data to and from medical
apparatus providing intravenous therapy to patients and to
and from medical apparatus monitoring the physiological
processes of patients undergoing intravenous therapy.
The present disclosure provides a method for flow rate compensation in devices, such as infusion pumps. In various embodiments, a computer-implemented method includes determining a location of a plurality of infusion pumps in a pump stack including the plurality of infusion pumps and a fluid supply connected to each of the plurality of infusion pumps. The computer-implemented method also includes determining a reference infusion pump, in the plurality of infusion pumps, and adjusting the flow rate for each infusion pump in the plurality of infusion pumps based on the distance between the infusion pump and the reference infusion pump.
A61M 5/142 - Perfusion sous pression, p. ex. utilisant des pompes
A61M 5/168 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte
A61M 5/172 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte électriques ou électroniques
The present invention provides a hemostatic composite sponge comprising oxidized cellulose and an essentially gelatin-free bioadhesive material stably associated with said sponge and present in an organized pattern on said sponge.
A61F 13/0203 - Bandages ou pansements adhésifs comportant des éléments de rétention de fluide
A61F 13/0246 - Bandages ou pansements adhésifs caractérisés par la couche adhérant à la peau
A61F 13/15 - Garnitures absorbantes, p. ex. serviettes ou tampons hygiéniques pour application externe ou interne au corpsMoyens pour les maintenir en place ou les fixerApplicateurs de tampons
A61L 15/22 - Bandages, pansements ou garnitures absorbant les fluides physiologiques tels que l'urine, le sang, p. ex. serviettes hygiéniques, tampons contenant des matériaux macromoléculaires
A hemodialysis system is disclosed. The hemodialysis system includes a dialyzer and an online dialysate generation system comprising a water inlet line and a drain line. The hemodialysis system also includes a disposable set comprising a supply tube fluidly connected to online dialysate generation system and a dialysate pumping tube fluidly connected to the dialyzer. The hemodialysis system further includes a dialysis instrument comprising a dialysate pump head and a motor positioned and arranged to operate the dialysate pump head. The dialysis instrument operates the dialysate pump head to move fresh dialysate from the online dialysate generation system through the dialysate pumping tube to the dialyzer.
A syringe pump including a housing with a syringe accepting region, an accelerometer configured to detect a tube pull, a syringe holding system configured to hold a syringe in the syringe accepting region, a drive mechanism, and a drive head operatively coupled to the drive mechanism. The drive head is configured to engage a piston of a syringe held by the syringe holding system.
A61M 5/142 - Perfusion sous pression, p. ex. utilisant des pompes
A61M 5/145 - Perfusion sous pression, p. ex. utilisant des pompes utilisant des réservoirs sous pression, p. ex. au moyen de pistons
A61M 5/168 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte
A peritoneal dialysis (“PD”) machine includes a water pump; a concentrate pump; a water valve, and an inlet to the water valve positioned to receive purified water; a concentrate valve, and an inlet to the concentrate valve positioned to receive PD fluid concentrate; a mixing line located downstream from the water pump and the a concentrate pump; a conductivity sensor positioned to sense mixed purified water and PD fluid concentrate that form fresh PD fluid; a flexible patient line configured to bring fresh PD fluid to and remove used PD fluid from a patient; and a control unit configured to control the water pump, the concentrate pump, the water valve and the concentrate valve, to receive an output from the conductivity sensor, and to run a disinfection sequence in which (i) the inlet to the concentrate valve alternatively receives disinfectant or (ii) the flexible patient line alternatively receives disinfectant.
A system includes a server including a clock and a plurality of medical devices in network communication with the server. Each medical device includes at least one alarm mechanism and an internal clock. A first medical device of the plurality of medical devices is configured to receive a clock synchronization data from the server, update the internal clock of the first medical device based on the clock synchronization data, provide an alarm signal of a first type at a first time, and provide a subsequent alarm signal of the first type at a second time. The second time occurs at a predetermined interval from the first time. Additionally, the second time is the same time the alarm signal of the first type is provided by a second medical device of the plurality of medical device.
G16H 20/17 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients administrés par perfusion ou injection
A61M 5/142 - Perfusion sous pression, p. ex. utilisant des pompes
G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
G16H 40/67 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement à distance
44.
DEVICE FOR ADMINISTRATION OF A THERAPEUTIC AGENT SOLUTION AND METHOD COMPRISING SAME
A device and method for parenteral administration of a solution of a therapeutic agent include a fluid reservoir having a chamber for holding fluid and an outlet port. The outlet port is fluidly coupled to a therapeutic agent conduit having a fluid inlet and a fluid outlet that define a fluid flow path. An infusion device is fluidly connected to the fluid outlet of the therapeutic agent conduit. The infusion device is capable of parenteral administration of fluid. A polymeric matrix is disposed in the therapeutic agent conduit, the polymeric matrix having a therapeutic agent dispersed therein. The therapeutic agent is at least partially dissolvable when contacted by fluid and a solution of the therapeutic agent is formed when contacted by the fluid.
A digital communication apparatus for transmission of data from a medical device is disclosed. In an example, the digital communication apparatus includes an input interface configured for communicative coupling to a medical device and an output interface configured for communicative coupling to a medical network and a remote server. A processor of the digital communication apparatus receives medical data in a first data format from the medical device via the input interface. The processor selects a first subset of the medical data for transmission in the first data format to the remote server via an Ethernet port or a wireless port of the output interface. The processor also converts a second subset of the medical data to the second data format and transmits the second subset of the medical data in the second data format to the medical network via a serial port or the Ethernet port.
G16H 40/20 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour la gestion ou l’administration de ressources ou d’établissements de soins de santé, p. ex. pour la gestion du personnel hospitalier ou de salles d’opération
G06F 13/42 - Protocole de transfert pour bus, p. ex. liaisonSynchronisation
G16H 10/60 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données spécifiques de patients, p. ex. pour des dossiers électroniques de patients
G16H 20/40 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des thérapies mécaniques, la radiothérapie ou des thérapies invasives, p. ex. la chirurgie, la thérapie laser, la dialyse ou l’acuponcture
G16H 30/20 - TIC spécialement adaptées au maniement ou au traitement d’images médicales pour le maniement d’images médicales, p. ex. DICOM, HL7 ou PACS
G16H 40/40 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour la gestion d’équipement ou de dispositifs médicaux, p. ex. pour planifier la maintenance ou les mises à jour
G16H 40/67 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement à distance
H04L 67/12 - Protocoles spécialement adaptés aux environnements propriétaires ou de mise en réseau pour un usage spécial, p. ex. les réseaux médicaux, les réseaux de capteurs, les réseaux dans les véhicules ou les réseaux de mesure à distance
A graph database for outbreak tracking and management is disclosed. In an example embodiment, an outbreak management system includes a memory device storing instructions that define a graph database for disease outbreak tracking. The instructions specify for a given host that a host node is created and an episode node is connected to the host node via a ‘case’ link. The episode node is associated with episode parameters that are related to a disease classification of the host. In addition, the instructions specify that an outbreak node is connected to the episode node via a ‘part of’ link to indicate that the host has become part of an outbreak of the disease. The outbreak node is connected to a definition node via a ‘defined as’ link. The definition node specifies disease parameters of the disease for outbreak tracking.
G06F 3/0484 - Techniques d’interaction fondées sur les interfaces utilisateur graphiques [GUI] pour la commande de fonctions ou d’opérations spécifiques, p. ex. sélection ou transformation d’un objet, d’une image ou d’un élément de texte affiché, détermination d’une valeur de paramètre ou sélection d’une plage de valeurs
G06F 16/901 - IndexationStructures de données à cet effetStructures de stockage
G06T 11/20 - Traçage à partir d'éléments de base, p. ex. de lignes ou de cercles
G16H 10/60 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données spécifiques de patients, p. ex. pour des dossiers électroniques de patients
G16H 50/80 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour la détection, le suivi ou la modélisation d’épidémies ou des pandémies, p. ex. de la grippe
G16H 70/60 - TIC spécialement adaptées au maniement ou au traitement de références médicales concernant des pathologies
A peritoneal dialysis system includes: a dialysis fluid pump including a pump actuator and a dialysis fluid contacting portion actuated by the pump actuator; a fresh dialysis fluid valve located upstream of the pump and including a fresh valve actuator and a dialysis fluid contacting portion actuated by the fresh valve actuator; a patient line valve located downstream of the pump and including a patient line valve actuator and a dialysis fluid contacting portion actuated by the patient line valve actuator; a drain valve positioned and arranged to receive used dialysis fluid from the patient and including a drain valve actuator and a dialysis fluid contacting portion; a patient line extending from the drain valve; and a fluid loop including dialysis fluid contacting portions of the pump, the fresh dialysis fluid valve, the patient line valve and the drain valve, and wherein the patient line extends from the fluid loop.
A packaged, sealed container system for stable storage of a formulation of an oxygen-sensitive pharmaceutical compound, the packaged, sealed container system comprising a primary container including therein a formulation of an oxygen-sensitive pharmaceutical compound, a secondary outer container comprising a first flexible sheet layer, an opposing second flexible sheet layer, and a seal disposed along a common peripheral edge of the first and second flexible sheet layers, such that the primary container is disposed between and enclosed by the first and second flexible sheet layers of the secondary outer container. An oxygen scavenger is also disposed between and enclosed by the first and second flexible sheet layers of the secondary outer container. The oxygen scavenger is in fluid communication with the contents of the primary container.
A61J 1/14 - Récipients spécialement adaptés à des fins médicales ou pharmaceutiques DétailsAccessoires à cet effet
A61M 1/14 - Systèmes de dialyseReins artificielsOxygénateurs du sang
A61M 5/00 - Dispositifs pour faire pénétrer des agents dans le corps par introduction sous-cutanée, intravasculaire ou intramusculaireAccessoires à cet effet, p. ex. dispositifs de remplissage ou de nettoyage, appuis-bras
A61M 5/14 - Dispositifs de perfusion, p. ex. perfusion par gravitéPerfusion sanguineAccessoires à cet effet
B65D 75/28 - Objets ou matériaux totalement enveloppés dans des enveloppes formées en associant ou reliant plusieurs feuilles ou flans
B65D 81/26 - Adaptations pour empêcher la détérioration ou l'altération du contenuApplications au réceptacle ou au matériau d'emballage d'agents de conservation des aliments, de fongicides, d'insecticides ou de produits repoussant les animaux avec dispositifs pour évacuer ou absorber les fluides, p. ex. s'écoulant du contenuEmploi de produits empêchant la corrosion ou de dessiccateurs
49.
Peritoneal dialysis cycler having dual peristaltic pumps
b) and terminating at a second connector, the second connector configured to be connected to the first connector to form the disposable set for use in the PD treatment.
A device and method for parenteral administration of a solution of a therapeutic agent include a fluid reservoir having a chamber for holding fluid and an outlet port. The outlet port is fluidly coupled to a therapeutic agent conduit having a fluid inlet and a fluid outlet that define a fluid flow path. An infusion device is fluidly connected to the fluid outlet of the therapeutic agent conduit. The infusion device is capable of parenteral administration of fluid. A polymeric matrix is disposed in the therapeutic agent conduit, the polymeric matrix having a therapeutic agent dispersed therein. The therapeutic agent is at least partially dissolvable when contacted by fluid and a solution of the therapeutic agent is formed when contacted by the fluid.
A renal failure therapy system for performing a peritoneal dialysis therapy is disclosed. The renal failure therapy system performs a plurality of peritoneal dialysis cycles for a patient and tracks an amount of dialysis fluid provided by a dialysis fluid pump during the plurality of peritoneal dialysis cycles. The renal failure therapy system also determines, as an initial drain volume, how much dialysis fluid resides in the patient's peritoneal cavity at a start of a next dialysis treatment and determines an initial drain flow for the next dialysis treatment. The renal failure therapy system generates an alert when it is determined from the initial drain flow that a low drain flow or a drain flow stoppage could occur before the initial drain volume is recovered for the start of the next dialysis treatment.
The invention relates to a flexible container/multi-chamber container with selective dissolved gas content for stabilizing at least one compound of a medical product having a selective gas requirement for remaining stable, comprising a solution comprising the at least one compound and a fil material from which the container is made that provides for high gas-barrier for the said gas. The at least one compound may be selenium in the form of Se(IV) and is preferably selected from the group consisting of sodium selenite, selenous acid and selenium dioxide. The selective gas may be oxygen, and the headspace of the oxygen maintains the solution to comprise dissolved oxygen (DO) at a level of 0.5 ppm to 8 ppm.
Devices, systems, and methods for monitoring patient hemodynamic status, systemic vascular resistance, reversal of cardiac and respiratory rates, and patient respiratory volume or effort are disclosed. A peripheral venous pressure is measured and used to detect levels, changes, or problems relating to patient blood volume. The peripheral venous pressure measurement is transformed from the time domain to the frequency domain for analysis. A heart rate frequency is identified, and harmonics of the heart rate frequency are detected and evaluated to determine, among other things, hypovolemia or hypervolemia, systemic vascular resistance, and of cardiac and respiratory rates, and patient respiratory volume or effort.
A61B 5/0215 - Mesure de la pression dans le cœur ou dans les vaisseaux sanguins par des moyens introduits dans le corps
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/02 - Détection, mesure ou enregistrement en vue de l'évaluation du système cardio-vasculaire, p. ex. mesure du pouls, du rythme cardiaque, de la pression sanguine ou du débit sanguin
A61B 5/024 - Mesure du pouls ou des pulsations cardiaques
A61B 5/0295 - Mesure du débit sanguin utilisant la pléthysmographie, c.-à-d. par mesure des variations du volume d'une partie du corps induites par la circulation du sang qui traverse cette partie, p. ex. pléthysmographie par impédance
A61B 5/08 - Dispositifs de mesure pour examiner les organes respiratoires
A61B 5/091 - Mesure du volume des gaz inspirés ou expirés, p. ex. pour déterminer la capacité pulmonaire
A61M 1/36 - Autre traitement du sang dans une dérivation du système circulatoire naturel, p. ex. adaptation de la température, irradiation
A61M 5/172 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte électriques ou électroniques
A61M 16/00 - Dispositifs pour agir sur le système respiratoire des patients par un traitement au gaz, p. ex. ventilateursTubes trachéaux
Example systems, methods, and apparatus are disclosed herein for on-screen parameter programming guidance based on user-inputted data and patient history graphical display generation based on a user-inputted command. The example systems, methods, and apparatus are configured to use a preloaded drug library to determine the upper and lower limits of parameters, and display a color graph and differently-colored text on a PCA pump user interface screen accordingly. Additionally, the example systems, methods, and apparatus are configured to use real-time patient history data to generate and display a patient history graph on a user interface screen. The disclosed systems, methods, and apparatus prevent human programming errors by minimizing the need for extensive user interaction with PCA pumps and the need to toggle between programming screens. Further, the disclosed systems, methods, and apparatus prevent human programming errors by displaying patient history in a single, consolidated graph.
A medical fluid container tubing assembly includes a medical fluid container, a luer connector including a luer port, a tube extending from the medical fluid container and terminating at the luer connector, and a cap fitted onto the luer connector. The cap includes a port sized to provide an interference fit with the luer port of the luer connector. The cap further includes a hydrophobic filter positioned and arranged to allow air to aseptically enter the tube to equalize pressure inside and outside of the tube. The cap may include an inner port including an inner surface tapered for forming an interference fit with an outer surface of a male luer port of a luer connector, an outer shroud sized to fit around an outer shroud of the luer connector, a lumen extending from the port to an opening, and a hydrophobic filter covering an opening formed by the lumen.
A61M 39/16 - Raccords ou accouplements pour tubes avec des dispositions pour la désinfection ou la stérilisation
A61M 39/20 - Couvercles ou bouchons d'obturation pour connecteurs ou extrémités ouvertes de tubes
A61L 2/07 - Procédés ou appareils de désinfection ou de stérilisation de matériaux ou d'objets autres que les denrées alimentaires ou les lentilles de contactAccessoires à cet effet utilisant des phénomènes physiques de la chaleur des gaz chauds de la vapeur
56.
AUTOMATIC SYRINGE PUMP NEAR EMPTY ALARM ACTIVATION THRESHOLD PROGRAMMING
Example systems, methods, and apparatus are disclosed herein for the automatic programming of a near empty alarm activation threshold based on an infusion therapy type selected by the user on a syringe pump. The example systems, methods, and apparatus are configured to use a preloaded drug library to determine if the selected infusion therapy type includes a PCA bolus or not, and define an appropriate time- or volume-based alarm activation threshold accordingly. The disclosed systems, methods, and apparatus prevent human programming errors by minimizing the need for extensive user interaction with syringe pumps. Further, the disclosed systems, methods, and apparatus allows for automatic programming to increase efficient infusion administration, and prevent programming errors that might result in patient discomfort or even injury.
G16H 20/17 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients administrés par perfusion ou injection
A61M 5/172 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte électriques ou électroniques
G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
A61M 5/168 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte
57.
METHODS, APPARATUS, AND SYSTEM FOR PAIRING A PATIENT'S MOBILE DEVICE WITH A MEDICAL DEVICE
Methods, apparatus, and systems for pairing a patient's mobile device with a medical device are disclosed. The methods, systems, and apparatus use a server that is securely connected to a medical device to manage a pairing process. The secure connection between the server and the medical device is used to transmit a certificate in addition to a phone number of a patient's mobile device. The server also transmits a pairing code to the medical device using the secure connection. The medical device displays the pairing code. A patient causes the mobile device to record the code, which is transmitted to the server to perform a congruency check by comparing the received code to the generated code. When the codes match, the server transmits a device identifier of the mobile device to the medical device, which enables the medical device to establish a secure proximity communication channel with the medical device.
G16H 10/00 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients
G16H 40/00 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux
H04W 4/80 - Services utilisant la communication de courte portée, p. ex. la communication en champ proche, l'identification par radiofréquence ou la communication à faible consommation d’énergie
58.
POWER ADAPTER WITH UNITED KINGDOM AND AUSTRALIA INTERCHANGEABLE BLADE WITH BUILT-IN FUSE IP-34 PROTECTION
Example systems, methods, and apparatus are disclosed herein for an interchangeable IPx4 UK blade with built-in fuse with a built-in fuse. The example systems, methods, and apparatus are configured to allow the user to replace used fuses from the interchangeable IPx4 UK blade with built-in fuse while providing water-sealing protection. Additionally, the example systems, methods, and apparatus are disclosed herein for an interchangeable IPx4 AU Blade. The disclosed systems, methods, and apparatus allow the user to use the interchangeable IPx4 AU Blade with all power adapters while providing water-sealing protection. Further, the disclosed systems, methods, and apparatus lower power adapter use cost by allowing the user to easily replace fuses without having to replace the entire power adapter. Finally, the disclosed systems, methods, and apparatus increase efficient power adapter use by orienting the power adapter such that electrical cords to not block unused power sockets.
H01R 13/688 - Association structurelle avec des composants électriques incorporés avec fusible incorporé le fusible étant amovible avec une partie boîtier adaptée pour accéder au fusible
H01R 31/06 - Pièces intermédiaires pour joindre deux pièces de couplage, p. ex. adaptateur
H01R 13/52 - Boîtiers protégés contre la poussière, les projections, les éclaboussures, l'eau ou les flammes
A medical fluid container tubing assembly includes a medical fluid container, a first luer connector, a tube extending from the medical fluid container and terminating at the first luer connector, and a cap fitted onto the first luer connector. The cap includes a hydrophobic filter positioned and arranged to allow air to aseptically enter the tube to equalize pressure inside and outside of the tube. The medical fluid container tubing assembly also includes a supply line extending from a medical fluid destination and terminating with a second luer connector. The second luer connector is configured to mate with the first luer connector when the cap is removed from the first luer connector.
Example systems, methods, and apparatus are disclosed herein for on-screen parameter programming guidance based on user-inputted data and patient history graphical display generation based on a user-inputted command. The example systems, methods, and apparatus are configured to use a preloaded drug library to determine the upper and lower limits of parameters, and display a color graph and differently-colored text on a PCA pump user interface screen accordingly. Additionally, the example systems, methods, and apparatus are configured to use real-time patient history data to generate and display a patient history graph on a user interface screen. The disclosed systems, methods, and apparatus prevent human programming errors by minimizing the need for extensive user interaction with PCA pumps and the need to toggle between programming screens. Further, the disclosed systems, methods, and apparatus prevent human programming errors by displaying patient history in a single, consolidated graph.
G16H 20/17 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients administrés par perfusion ou injection
A61M 5/142 - Perfusion sous pression, p. ex. utilisant des pompes
G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
61.
VENTED MEDICAL FLUID SUPPLY LINE CAP, ASSEMBLY AND METHOD THEREFOR
A medical fluid container tubing assembly includes a medical fluid container, a luer connector including a luer port, a tube extending from the medical fluid container and terminating at the luer connector, and a cap fitted onto the luer connector. The cap includes a port sized to provide an interference fit with the luer port of the luer connector. The cap further includes a hydrophobic filter positioned and arranged to allow air to aseptically enter the tube to equalize pressure inside and outside of the tube. The cap may include an inner port including an inner surface tapered for forming an interference fit with an outer surface of a male luer port of a luer connector, an outer shroud sized to fit around an outer shroud of the luer connector, a lumen extending from the port to an opening, and a hydrophobic filter covering an opening formed by the lumen.
A61M 39/20 - Couvercles ou bouchons d'obturation pour connecteurs ou extrémités ouvertes de tubes
A61L 2/07 - Procédés ou appareils de désinfection ou de stérilisation de matériaux ou d'objets autres que les denrées alimentaires ou les lentilles de contactAccessoires à cet effet utilisant des phénomènes physiques de la chaleur des gaz chauds de la vapeur
A61M 39/00 - Tubes, raccords ou accouplements pour tubes, soupapes, voies d'accès ou similaires, spécialement adaptés pour un usage médical
62.
DIALYSIS SYSTEM HAVING ADAPTIVE PRESCRIPTION MANAGEMENT
An example peritoneal dialysis system is disclosed. The example peritoneal dialysis system includes at least one pump and a memory device configured to store therapy prescriptions including a first ultrafiltration (“UF”) therapy prescription for removing ultrafiltrate from a patient, and a second UF therapy prescription for removing less ultrafiltrate from the patient compared to the first UF therapy prescription. The system further includes a logic implementer configured to receive UF removed data, use the UF removed data to form or update a moving average UF removed trend, and compare the moving average UF removed trend to an expected UF removal trend or an expected UF removal minimum value. When the moving average UF removed trend is below the expected UF removal trend or the expected UF removal minimum value, the logic implementer provides a recommendation that the first UF therapy prescription should be selected for a next peritoneal dialysis treatment.
G16H 20/40 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des thérapies mécaniques, la radiothérapie ou des thérapies invasives, p. ex. la chirurgie, la thérapie laser, la dialyse ou l’acuponcture
63.
PORT ARRANGEMENT, A PURIFIED WATER PRODUCING APPARATUS COMPRISING THE PORT ARRANGEMENT AND A METHOD FOR PERFORMING PORT CLEANING OF A PURIFIED WATER PRODUCING APPARATUS
A method for performing port cleaning of an apparatus having a casing, a fluid circuit enclosed inside the casing, and a port arrangement. The method includes producing a cleaning fluid with the fluid circuit; passing the cleaning fluid through a first port via a first tube of the first port to a first circumferential space, from the first circumferential space via a bypass channel to a second circumferential space, and thereafter to a second tube of a second port; and passing the cleaning fluid from the second tube to a drain.
A61M 39/16 - Raccords ou accouplements pour tubes avec des dispositions pour la désinfection ou la stérilisation
C02F 1/68 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout par addition de substances spécifiées, pour améliorer l'eau potable, p. ex. par addition d'oligo-éléments
64.
POWER ADAPTER WITH UNITED KINGDOM AND AUSTRALIA INTERCHANGEABLE BLADE WITH BUILT-IN FUSE IP-34 PROTECTION
Example systems, methods, and apparatus are disclosed herein for an interchangeable IPx4 UK blade with built-in fuse with a built-in fuse. The example systems, methods, and apparatus are configured to allow the user to replace used fuses from the interchangeable IPx4 UK blade with built-in fuse while providing water-sealing protection. Additionally, the example systems, methods, and apparatus are disclosed herein for an interchangeable IPx4 AU Blade. The disclosed systems, methods, and apparatus allow the user to use the interchangeable IPx4 AU Blade with all power adapters while providing water-sealing protection. Further, the disclosed systems, methods, and apparatus lower power adapter use cost by allowing the user to easily replace fuses without having to replace the entire power adapter. Finally, the disclosed systems, methods, and apparatus increase efficient power adapter use by orienting the power adapter such that electrical cords to not block unused power sockets.
H01R 13/692 - Association structurelle avec des composants électriques incorporés avec fusible incorporé le fusible étant amovible avec une partie boîtier adaptée pour accéder au fusible la partie boîtier étant susceptible de rotation
H01R 13/213 - Broches, lames ou alvéoles conformés ou ayant une pièce séparée en vue de retenir ensemble les parties en fonctionnement par connexion à baïonnette
H01R 13/22 - Contacts pour coopération par aboutage
H01R 13/62 - Moyens pour faciliter l'engagement ou la séparation des pièces de couplage ou pour les maintenir engagées
H01R 13/625 - Boîtier ou bague à couplage à baïonnette
H01R 13/629 - Moyens additionnels pour faciliter l'engagement ou la séparation des pièces de couplage, p. ex. moyens pour aligner ou guider, leviers, pression de gaz
H01R 13/635 - Moyens additionnels pour faciliter l'engagement ou la séparation des pièces de couplage, p. ex. moyens pour aligner ou guider, leviers, pression de gaz pour la séparation uniquement par une pression mécanique, p. ex. par la force d'un ressort
H01R 31/06 - Pièces intermédiaires pour joindre deux pièces de couplage, p. ex. adaptateur
65.
AUTOMATIC SYRINGE PUMP NEAR EMPTY ALARM ACTIVATION THRESHOLD PROGRAMMING
Example systems, methods, and apparatus are disclosed herein for the automatic programming of a near empty alarm activation threshold based on an infusion therapy type selected by the user on a syringe pump. The example systems, methods, and apparatus are configured to use a preloaded drug library to determine if the selected infusion therapy type includes a PCA bolus or not, and define an appropriate time- or volume-based alarm activation threshold accordingly. The disclosed systems, methods, and apparatus prevent human programming errors by minimizing the need for extensive user interaction with syringe pumps. Further, the disclosed systems, methods, and apparatus allows for automatic programming to increase efficient infusion administration, and prevent programming errors that might result in patient discomfort or even injury.
A61M 5/172 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte électriques ou électroniques
66.
DUAL CHAMBER MEDICAL FLUID CONTAINER WITH VENTED SUPPLY LINE CAP AND METHOD THEREFOR
A medical fluid container tubing assembly includes a medical fluid container, a first luer connector, a tube extending from the medical fluid container and terminating at the first luer connector, and a cap fitted onto the first luer connector. The cap includes a hydrophobic filter positioned and arranged to allow air to aseptically enter the tube to equalize pressure inside and outside of the tube. The medical fluid container tubing assembly also includes a supply line extending from a medical fluid destination and terminating with a second luer connector. The second luer connector is configured to mate with the first luer connector when the cap is removed from the first luer connector.
A medical fluid delivery machine including: a medical fluid pump including a pneumatically actuated pump chamber and first and second pneumatically actuated medical fluid valve chambers located respectively upstream and downstream of the pneumatically actuated pump chamber; a vacuum pump for creating negative pressure; and an accumulator storing the negative pressure for operation with at least one of the pneumatically actuated pump chamber, the first pneumatically actuated medical fluid valve chamber or the second pneumatically actuated medical fluid valve chamber, the accumulator holding an elastic bladder that inflates under negative pressure from the vacuum pump applied to an outside of the elastic bladder, creating additional negative pressure that increases the amount of negative pressure that the accumulator can provide.
F04B 7/02 - "Machines" ou pompes à piston caractérisées par un entraînement desmodromique des organes du mécanisme de distribution le mécanisme de distribution étant actionnés par un fluide
F04B 9/12 - "Machines" ou pompes à piston caractérisées par les moyens entraînants ou entraînés liés à leurs organes de travail les moyens étant à fluide le fluide étant compressible, p. ex. de la vapeur ou de l'air
F04B 9/123 - "Machines" ou pompes à piston caractérisées par les moyens entraînants ou entraînés liés à leurs organes de travail les moyens étant à fluide le fluide étant compressible, p. ex. de la vapeur ou de l'air avec une seule chambre de pompage
F04B 9/127 - "Machines" ou pompes à piston caractérisées par les moyens entraînants ou entraînés liés à leurs organes de travail les moyens étant à fluide le fluide étant compressible, p. ex. de la vapeur ou de l'air avec une seule chambre de pompage le mouvement rectiligne de l'organe de pompage dans le sens de travail étant obtenu par un moteur à simple effet à fluide compressible, p. ex. actionné dans l'autre sens par gravité ou par un ressort
F04B 23/02 - Installations ou systèmes de pompage comportant des réservoirs
F04B 23/08 - Combinaisons de plusieurs pompes les pompes étant de différents types
F04B 39/10 - Adaptation ou aménagement des organes de distribution
F04B 41/02 - Installations ou systèmes de pompage spécialement adaptés aux fluides compressibles comportant des réservoirs
F04B 43/073 - Pompes ayant un entraînement par fluide le fluide d'entraînement étant commandé par au moins un clapet
A dialysis system having motor driven pressure estimation of fluid within a patient line is disclosed. A peritoneal dialysis (“PD”) system includes a fluid pump and a patient line that fluidly couples the fluid pump to an indwelling catheter leading into a patient's peritoneal cavity. The PD system also includes a motor driver that controls a motor of the fluid pump and transmits an output signal that is indicative of a load on the motor. The PD system further includes a machine learning algorithm that associates data related to output signals from motor drivers with known fluid pressures within patient lines. A processor of the PD system transmits an input signal to activate the motor driver, receives the output signal from the motor driver, and estimates a fluid pressure within the patient line by applying the data from the received output signal to the machine learning algorithm.
A dialysis system having motor driven pressure estimation of fluid within a patient line is disclosed. A peritoneal dialysis ("PD") system includes a fluid pump and a patient line that fluidly couples the fluid pump to an indwelling catheter leading into a patient's peritoneal cavity. The PD system also includes a motor driver that controls a motor of the fluid pump and transmits an output signal that is indicative of a load on the motor. The PD system further includes a machine learning algorithm that associates data related to output signals from motor drivers with known fluid pressures within patient lines. A processor of the PD system transmits an input signal to activate the motor driver, receives the output signal from the motor driver, and estimates a fluid pressure within the patient line by applying the data from the received output signal to the machine learning algorithm.
A water purification apparatus capable of being cleaned at a point of care and methods for cleaning the water purification apparatus at the point of care are disclosed herein. The water purification apparatus and the methods provide an efficient use of a heater for heat disinfection the water purification apparatus. The water purification apparatus and the methods provide heat disinfection by recirculating heated fluid to further heat the fluid. Several different cleaning programs are provided that may be utilized for cleaning different parts of the water purification apparatus.
B01D 61/48 - Appareils à cet effet ayant un ou plusieurs compartiments remplis d'un matériau échangeur d'ions
C02F 1/00 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout
C02F 1/28 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout par absorption ou adsorption
C02F 1/44 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout par dialyse, osmose ou osmose inverse
C02F 1/469 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout par des procédés électrochimiques par séparation électrochimique, p. ex. par électro-osmose, électrodialyse, électrophorèse
A peritoneal dialysis ("PD") disinfection device includes a top made of a material configured to let light pass through the material, a bottom, a printed circuit board ("PCB") secured between the top and the bottom, a plurality of ultraviolet light emitting diodes ("UV-LEDs") secured to the PCB, and a power source operable to supply power to the plurality of UV-LEDs. At least one of the top, the bottom, and the PCB includes a feature that enables a patient to locate and orient the PD disinfection device so that UV light from the plurality of UV-LEDs is directed towards a connection end of the patient's catheter or a catheter/patient exit site.
A61L 2/10 - Procédés ou appareils de désinfection ou de stérilisation de matériaux ou d'objets autres que les denrées alimentaires ou les lentilles de contactAccessoires à cet effet utilisant des phénomènes physiques des radiations des ultraviolets
A61M 39/18 - Procédés ou appareils pour réaliser les connexions sous conditions stériles
A61M 39/16 - Raccords ou accouplements pour tubes avec des dispositions pour la désinfection ou la stérilisation
09 - Appareils et instruments scientifiques et électriques
Produits et services
(1) Logiciel médical téléchargeable pour la réception, le stockage, l'affichage et la transmission de données à destination et en provenance d'appareils médicaux fournissant une thérapie intraveineuse aux patients et à destination et en provenance d'appareils médicaux surveillant les processus physiologiques des patients soumis à une thérapie intraveineuse.
73.
DIALYSIS SYSTEM HAVING REDUCED VALVE NOISE AND VALVE POSITION DETECTION
Systems and methods are disclosed for reducing valve noise and detecting a valve position in medical fluid systems. One method includes transmitting, by a microcontroller, a control signal for closing a valve via pulse width modulation (PWM) signals. The valve is configured to control a fluid flow in the medical fluid system. The valve may be open at least before the control signal is transmitted. The valve comprises a housing, a solenoid coil, and a plunger. The method further includes applying power to the valve to measure voltage across the valve and monitoring, based on a sense resistor, the voltage across the valve over a measurement interval. The measurement interval terminates when the voltage reaches a predetermined threshold voltage. The method also includes comparing the measurement interval to a reference interval for a normally functioning closed valve and generating, based on the comparison, an assessment of the valve position.
A peritoneal dialysis ("PD") system includes a PD machine and a docking station connected to the PD machine via a power cord. The docking station includes a plurality of connectors configured to receive a cable of one or more wired peripheral entity, a transceiver for wireless communication with one or more wireless peripheral entity, and a power supply rated to power the PD machine during a PD treatment that includes batch or inline PD fluid heating.
Systems and methods are disclosed for assessing the functionality of solenoid valve activation in peritoneal dialysis systems. In at least one embodiment, measurements of current values may be received from a solenoid valve at a predetermined sampling rate over a predetermine duration of time to generate a current profile for the solenoid valve. A fifth degree polynomial model may be fit to the current profile and optimized. The optimized polynomial model may be applied to a trained support vector machine to determine whether the current profile indicates that the corresponding solenoid valve has actually opened or closed.
A61M 1/14 - Systèmes de dialyseReins artificielsOxygénateurs du sang
F16K 37/00 - Moyens particuliers portés par ou sur les soupapes ou autres dispositifs d'obturation pour repérer ou enregistrer leur fonctionnement ou pour permettre de donner l'alarme
F16K 31/06 - Moyens de fonctionnementDispositifs de retour à la position de repos électriquesMoyens de fonctionnementDispositifs de retour à la position de repos magnétiques utilisant un aimant
H01F 7/18 - Circuits en vue d'obtenir des caractéristiques de fonctionnement souhaitées, p. ex. pour un fonctionnement lent, pour l'excitation successive des enroulements, pour l'excitation à grande vitesse des enroulements
76.
DIALYSIS SYSTEM HAVING A VALVE FUNCTIONALITY ASSESSMENT
Systems and methods are disclosed for assessing the functionality of solenoid valve activation in peritoneal dialysis systems. In at least one embodiment, measurements of current values may be received from a solenoid valve at a predetermined sampling rate over a predetermine duration of time to generate a current profile for the solenoid valve. A fifth degree polynomial model may be fit to the current profile and optimized. The optimized polynomial model may be applied to a trained support vector machine to determine whether the current profile indicates that the corresponding solenoid valve has actually opened or closed.
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
A61M 1/14 - Systèmes de dialyseReins artificielsOxygénateurs du sang
Systems and methods are disclosed for reducing noise in solenoid valve activation and deactivation in peritoneal dialysis (“PD”) systems. In at least one embodiment, the PD system operates with solenoid valves under the control of a control unit. The control unit takes measures to control the movement of the solenoid valve to minimize the amount of sound that occurs at impact during activation and deactivation of the valve. The measures include the slowing of the movement of the valve plunger within the valve coil. In one aspect, the valve plunger may be slowed down by applying voltage to the valve coil through pulse width modulation (“PWM”).
A dry concentrate bag for preparing a dialysis fluid comprising one or more plastic films defining two welded together to define a housing space for the dry concentrate; a dry concentrate housed within the housing space; an inlet portion placed in correspondence of a bottom area in use conditions of the dry concentrate bag and comprising an inlet port for receiving a fluid; an outlet portion placed in correspondence of a top area in use conditions of the dry concentrate bag and comprising an outlet port for letting the fluid mixed with the dry concentrate to leave the housing space. The inlet portion comprises a first and a second inclined welding lines both emerging from the inlet port and defining a lower cone portion of the housing space, the inlet port being placed at the lowest point of the lower cone portion, wherein the outlet portion comprises a third and a fourth inclined welding lines both converging to the outlet port and defining an upper cone portion of the housing space, the outlet port being placed at the highest point of the upper cone portion.
A medical fluid generation apparatus is provided with a fluid circuit including a main fluid line having an inlet for receiving water, a pump active on the main fluid line to circulate fluid, a plurality of valves on the fluid circuit configurable to define different fluid paths for the fluid inside the fluid circuit, a supporting structure having a first primary container access for fluid communication with a primary concentrate container and a first auxiliary container access for fluid communication with an auxiliary concentrate container, a mixing container having an inlet and an outlet. The fluid circuit comprises a medical fluid outlet placed downstream the pump; a mixing container outlet line connecting the outlet of the mixing container to a first junction point on the main fluid line placed upstream the pump; a mixing container inlet line connecting a sixth junction point on the main fluid line downstream the pump to the inlet of the mixing container; a primary concentrate container outlet line connecting the first primary container access to a fifth junction point on the main fluid line upstream the; an auxiliary concentrate container outlet line connecting the first auxiliary container access to a third junction point on the main fluid line upstream the pump.
A medical fluid generation apparatus comprises a fluid circuit including a main fluid line; a pump on the main fluid line; a plurality of valves to define different fluid paths for the fluid inside the fluid circuit; a mixing container having an inlet and an outlet both in fluid communication with the main fluid line; a sensor connected to the main fluid line to measure a property of the fluid flowing in the main fluid line; the fluid paths comprise a mixing recirculation path including the outlet, a portion of the main fluid line on which the pump operates, and the inlet A control unit controls the plurality of valves to set the mixing recirculation path and to allow a recirculation of the fluid contained in the mixing container through the mixing recirculation path. The control unit is further configured to recirculate the fluid in the mixing recirculation path; detect a time-resolved variation of the property of the fluid recirculating in the mixing recirculating path (the time-resolved variation of said property of the fluid is related to homogeneity of the fluid recirculating in the mixing recirculating path); interrupt the recirculation step upon the time-resolved variation meeting a variation criterion.
Systems and methods are disclosed for reducing valve noise and detecting a valve position in medical fluid systems. One method includes transmitting, by a microcontroller, a control signal for closing a valve via pulse width modulation (PWM) signals. The valve is configured to control a fluid flow in the medical fluid system. The valve may be open at least before the control signal is transmitted. The valve comprises a housing, a solenoid coil, and a plunger. The method further includes applying power to the valve to measure voltage across the valve and monitoring, based on a sense resistor, the voltage across the valve over a measurement interval. The measurement interval terminates when the voltage reaches a predetermined threshold voltage. The method also includes comparing the measurement interval to a reference interval for a normally functioning closed valve and generating, based on the comparison, an assessment of the valve position.
Systems and methods are disclosed for reducing noise in solenoid valve activation and deactivation in peritoneal dialysis ("PD") systems. In at least one embodiment, the PD system operates with solenoid valves under the control of a control unit. The control unit takes measures to control the movement of the solenoid valve to minimize the amount of sound that occurs at impact during activation and deactivation of the valve. The measures include the slowing of the movement of the valve plunger within the valve coil. In one aspect, the valve plunger may be slowed down by applying voltage to the valve coil through pulse width modulation ("PWM").
An infusion pump for pumping fluid through an administrative set at a desired flow rate over a specified duration, and includes a pumping mechanism for releasably receiving and for exerting a pulsing force on the administrative set, thus pressurizing a portion of the set for creating a flow of fluid from a set outlet. A controller is connected to and is configured for operating the pumping mechanism, the controller determines a pulse frequency based on a volume of fluid infused over a portion of the specified duration and the desired flow rate, outputs a control signal to the pumping mechanism for operating the pumping mechanism based on the determined pulse frequency, determines a first pulse frequency based on the desired flow rate; and adjusts the first pulse frequency based on the volume of fluid infused to provide a second pulse frequency being different from the first pulse frequency.
A61M 5/168 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte
A61M 5/142 - Perfusion sous pression, p. ex. utilisant des pompes
A61M 5/172 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte électriques ou électroniques
84.
METHOD AND SYSTEM FOR PRODUCING STERILE SOLUTION PRODUCT BAGS
A method for producing sterile solution product bags includes positioning a manifold assembly onto a filling machine. The manifold assembly includes a plurality of bags, a first filter, and a connection line in fluid communication with the first filter. Each of the plurality of bags includes a bladder and a stem in fluid communication with the bladder and with the connection line. The method includes activating a pump and at least partially filling one or more of the bladders by pumping fluid through the feed line, the first filter, and the connection line. The method includes sealing the stem of each of the filled product bags at a location between the connection line and the bladder, thereby creating one or more at least partially filled and sealed product bags. The method includes separating each of the at least partially filled and sealed product bags from the connection line.
B65B 3/00 - Emballage de matériaux plastiques, de semi-liquides, de liquides ou de liquides et solides mélangés, dans des réceptacles ou récipients individuels, p. ex. dans des sacs ou sachets, boîtes, cartons, bidons ou pots
B29C 65/00 - Assemblage d'éléments préformésAppareils à cet effet
B29C 65/74 - Assemblage d'éléments préformésAppareils à cet effet par soudage et découpage
B65B 1/18 - Procédés ou moyens pour remplir les réceptacles ou les récipients avec le matériau pour le remplissage des sacs à valves
B65B 7/02 - Fermeture des réceptacles ou récipients déformés par le contenu ou en prenant la forme, p. ex. sacs
B65B 51/14 - Application ou production de chaleur ou de pression ou les deux à la fois par éléments oscillants ou à mouvement alternatif
B65B 57/14 - Dispositifs de commande automatique, de vérification, d'alarme ou de sécurité sensibles à l'absence, à la présence, à l'alimentation anormale ou au mauvais positionnement des objets ou matériaux à emballer et dont le fonctionnement commande ou arrête l'alimentation des objets ou matériaux à emballer
B65B 57/18 - Dispositifs de commande automatique, de vérification, d'alarme ou de sécurité déclenchant des signaux d'alarme acoustiques ou optiques
An automated peritoneal dialysis apparatus includes at least one pump and a memory device configured to simultaneously store a first standard ultrafiltration (“UF”) therapy prescription with a longer duration and a lower dextrose concentration and a second standard UF therapy prescription with a shorter duration and a higher dextrose concentration. A logic implementer of the automated peritoneal dialysis apparatus is programmed to receive a patient weight value and determine a weight difference between the patient weight value and at least one prior patient weight value. When the weight difference is below a threshold, the logic implementer causes the first standard UF therapy prescription and the second standard UF therapy prescription to be displayed as possible options for selection and when the weight difference is above the threshold, the logic implementer prevents the second standard UF therapy prescription from being displayed as a possible option for selection.
A61M 1/14 - Systèmes de dialyseReins artificielsOxygénateurs du sang
G06Q 10/087 - Gestion d’inventaires ou de stocks, p. ex. exécution des commandes, approvisionnement ou régularisation par rapport aux commandes
G16H 20/10 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients
G16H 20/40 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des thérapies mécaniques, la radiothérapie ou des thérapies invasives, p. ex. la chirurgie, la thérapie laser, la dialyse ou l’acuponcture
86.
PERISTALTIC PUMP EQUIPPED WITH A RELEASE SYSTEM TO DISENGAGE THE FLUID TUBE
Disclosed herein is a peristaltic pump configured to receive a fluid line and comprising a stator having a pump race, a rotor surrounded by the pump race and configured to rotate about a rotor axis. The rotor comprises a contrasting element configured to abut against the fluid line. The contrasting element is movable between a released position where the contrasting element is away from the pump race, and an operative position where the at least one contrasting element is approached to the pump race and configured to abut against the fluid line. In the released position, the contrasting element is at a distance from the pump race higher than in the operative position. The peristaltic pump further comprises a releasing member borne by the stator and movable between an active position and a rest position, where the releasing member is spatially shifted with respect to the rotor axis.
Extracorporeal blood treatment apparatus, methods, and systems to perform an extracorporeal blood treatment using an organic filter operable to perform the functions of an organ are described herein. The extracorporeal blood treatment apparatus includes a treatment set, a high flow pump, a first low flow pump, and a second low flow pump, and a computing apparatus operatively coupled to the extracorporeal blood treatment apparatus. The computing apparatus may be configured to perform an extracorporeal blood treatment using the extracorporeal blood treatment apparatus and the organic filter.
The present disclosure provides devices and methods of using same for cleansing a solution (e.g., a salt or used dialysis solution) of urea via electrooxidation, and more specifically to cleansing a renal therapy solution/dialysis solution of urea via electrooxidation so that the renal therapy solution/dialysis solution can be used or reused for treatment of a patient. In an embodiment, a device for the removal of urea from a fluid having urea to produce a cleansed fluid includes a urea decomposition unit and an electrodialysis unit.
C02F 1/461 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout par des procédés électrochimiques par électrolyse
C02F 1/467 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout par des procédés électrochimiques par électrolyse par désinfection électrochimique
C02F 1/469 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout par des procédés électrochimiques par séparation électrochimique, p. ex. par électro-osmose, électrodialyse, électrophorèse
C02F 101/16 - Composés de l'azote, p. ex. ammoniac
A virtual assistant/chatbot to improve clinical workflow for home renal replacement therapies is disclosed herein. A virtual assistant/chatbot includes a user interface configured to enable a patient to engage in a virtual chat session by typing, speaking, or otherwise providing information regarding a patient request or issue related to their renal replacement therapy. The virtual assistant/chatbot also includes a server configured to provide logic to respond to the patient's requests. The logic defines a sequence of questions and answers for resolving patient queries. The sequence of assistant/chatbot questions and patient answers may be configured in a node arrangement such that certain patient answers/requests lead to additional questions for additional information from a patient. The virtual assistant/chatbot is configured to answer patient requests automatically or determine when the patient request is to be immediately addressed by a clinician or later through a phone call, text, or email communication.
G16H 10/20 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des essais ou des questionnaires cliniques électroniques
G10L 15/22 - Procédures utilisées pendant le processus de reconnaissance de la parole, p. ex. dialogue homme-machine
G10L 15/26 - Systèmes de synthèse de texte à partir de la parole
H04L 51/02 - Messagerie d'utilisateur à utilisateur dans des réseaux à commutation de paquets, transmise selon des protocoles de stockage et de retransmission ou en temps réel, p. ex. courriel en utilisant des réactions automatiques ou la délégation par l’utilisateur, p. ex. des réponses automatiques ou des messages générés par un agent conversationnel
H04L 67/10 - Protocoles dans lesquels une application est distribuée parmi les nœuds du réseau
90.
SYSTEM FOR REMOVING UREMIC TOXINS IN DIALYSIS PROCESSES
A method of performing dialysis includes: recirculating a dialysis fluid from a patient or a dialyzer for at least two cycles, each cycle contacting the dialysis fluid first with a zirconium phosphate layer followed by at least one of a urease layer, a zirconium oxide layer, or a carbon layer; storing the recirculated dialysis fluid in a storage container; and transferring the dialysis fluid from the storage container to the patient or the dialyzer. In one example, the zirconium phosphate layer and the at least one of the urease layer, the zirconium oxide layer, or the carbon layer is provided by a sorbent cartridge.
A61M 1/36 - Autre traitement du sang dans une dérivation du système circulatoire naturel, p. ex. adaptation de la température, irradiation
B01J 20/02 - Compositions absorbantes ou adsorbantes solides ou compositions facilitant la filtrationAbsorbants ou adsorbants pour la chromatographieProcédés pour leur préparation, régénération ou réactivation contenant une substance inorganique
B01J 20/06 - Compositions absorbantes ou adsorbantes solides ou compositions facilitant la filtrationAbsorbants ou adsorbants pour la chromatographieProcédés pour leur préparation, régénération ou réactivation contenant une substance inorganique contenant des oxydes ou des hydroxydes des métaux non prévus dans le groupe
B01J 20/20 - Compositions absorbantes ou adsorbantes solides ou compositions facilitant la filtrationAbsorbants ou adsorbants pour la chromatographieProcédés pour leur préparation, régénération ou réactivation contenant une substance inorganique contenant du carbone libreCompositions absorbantes ou adsorbantes solides ou compositions facilitant la filtrationAbsorbants ou adsorbants pour la chromatographieProcédés pour leur préparation, régénération ou réactivation contenant une substance inorganique contenant du carbone obtenu par des procédés de carbonisation
B01J 20/24 - Composés macromoléculaires d'origine naturelle, p. ex. acides humiques ou leurs dérivés
B01J 20/28 - Compositions absorbantes ou adsorbantes solides ou compositions facilitant la filtrationAbsorbants ou adsorbants pour la chromatographieProcédés pour leur préparation, régénération ou réactivation caractérisées par leur forme ou leurs propriétés physiques
A wearable peritoneal dialysis system includes a PD fluid supply assembly including an outer container, and an inner PD fluid supply container sealed within the outer container; a pumping unit including an air pump having a positive pressure outlet and a negative pressure outlet; a PD fluid drain assembly including an outer leg container configured to be worn around a patient's leg, an inner PD fluid drain container sealed within the outer leg container; and a control unit configured to cause (i) positive pneumatic pressure to be supplied from the positive pressure outlet to the outer container to force fresh PD fluid to flow from the inner PD fluid supply container to the patient and (ii) negative pneumatic pressure to be supplied from the negative pressure outlet to the inner container to force used PD fluid to flow from the patient towards the inner PD fluid drain container.
In one example, a control unit causes (i) a second pneumatic valve and a source fluid valve to open and a linear actuator to move a piston head into a first cylinder chamber so as to create a negative pressure in a pneumatic pump chamber, pulling source fluid into a fluid pump chamber and (ii) a first pneumatic valve and a destination fluid valve to open and the linear actuator to move the piston head into the first cylinder chamber, pushing the source fluid through the destination fluid valve, the control unit using a pressure sensor reading to control the linear actuator so that a final pressure for (ii) at least substantially equals an initial pressure for (ii), such that a volume of space corresponding to the movement of piston head within the cylinder during (ii) equals a volume of the source fluid delivered from fluid pump chamber.
A renal therapy system is disclosed. In an example, the renal therapy system includes a home renal therapy machine that stores, to a log file, dates of when renal therapies were performed and a type of each renal therapy that was performed. The system also includes a server that receives the log file from the home renal therapy machine. The server compares the dates and types of performed renal therapies stored in the log file to a device program that specifies dates for performing renal therapies and the types of renal therapies to be performed. The server displays a flag in a user interface of a clinician computer when there is a deviation from the comparison.
G16H 10/60 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données spécifiques de patients, p. ex. pour des dossiers électroniques de patients
G16H 20/10 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients
G16H 20/17 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients administrés par perfusion ou injection
G16H 20/40 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des thérapies mécaniques, la radiothérapie ou des thérapies invasives, p. ex. la chirurgie, la thérapie laser, la dialyse ou l’acuponcture
G16H 40/40 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour la gestion d’équipement ou de dispositifs médicaux, p. ex. pour planifier la maintenance ou les mises à jour
G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
G16H 40/67 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement à distance
94.
DIALYSIS SYSTEM HAVING EXTERNAL TUBING SURFACE CLEANING
A peritoneal dialysis ("PD") system includes a housing, a PD fluid pump housed by the housing, and a reusable line in fluid communication with the PD fluid pump. The reusable line is configured to be pulled into the housing. The PD system also includes an external tubing surface cleaning unit positioned and arranged to at least one of (i) remove debris from at least a portion of the exterior of the reusable line as it is pulled into the housing, or (ii) apply disinfectant to at least the portion of the exterior of the reusable line as it is pulled into the housing.
A peritoneal dialysis ("PD") system includes a housing, a PD fluid pump housed by the housing, an inline heater in fluid communication with the PD fluid pump, a temperature sensor, and a control unit. The PD fluid pump and the inline heater are under control of the control unit, which receives a temperature signal from the temperature sensor. The control unit, in one embodiment, is configured to perform a heat disinfection sequence in which the control unit causes the PD fluid pump to pump disinfection fluid in a forward direction, while the inline heater heats the disinfection fluid, and in a reverse direction after the temperature signal indicates that a temperature of the disinfection fluid has fallen to or has fallen below a minimum disinfection temperature.
A peritoneal dialysis (“PD”) system includes a housing, a PD fluid pump housed by the housing, and a reusable line in fluid communication with the PD fluid pump. The reusable line is configured to be pulled into the housing. The PD system also includes an external tubing surface cleaning unit positioned and arranged to at least one of (i) remove debris from at least a portion of the exterior of the reusable line as it is pulled into the housing, or (ii) apply disinfectant to at least the portion of the exterior of the reusable line as it is pulled into the housing.
A61L 2/18 - Procédés ou appareils de désinfection ou de stérilisation de matériaux ou d'objets autres que les denrées alimentaires ou les lentilles de contactAccessoires à cet effet utilisant des substances chimiques des substances liquides
A peritoneal dialysis (“PD”) system includes a housing, a PD fluid pump housed by the housing, an inline heater in fluid communication with the PD fluid pump, a temperature sensor, and a control unit. The PD fluid pump and the inline heater are under control of the control unit, which receives a temperature signal from the temperature sensor. The control unit, in one embodiment, is configured to perform a heat disinfection sequence in which the control unit causes the PD fluid pump to pump disinfection fluid in a forward direction, while the inline heater heats the disinfection fluid, and in a reverse direction after the temperature signal indicates that a temperature of the disinfection fluid has fallen to or has fallen below a minimum disinfection temperature.
The invention provides a neck-worn sensor (referred to herein as the ‘necklace’) that is a single, body-worn system that measures the following parameters from an ambulatory patient: heart rate, pulse rate, pulse oximetry, respiratory rate, temperature, thoracic fluid levels, stroke volume, cardiac output, and a parameter sensitive to blood pressure called pulse transit time. From stroke volume, a first algorithm employing a linear model can estimate the patient's pulse pressure. And from pulse pressure and pulse transit time, a second algorithm, also employing a linear algorithm, can estimate systolic blood pressure and diastolic blood pressure. Thus, the necklace can measure all five vital signs along with hemodynamic parameters. It also includes a motion-detecting accelerometer, from which it can determine motion-related parameters such as posture, degree of motion, activity level, respiratory-induced heaving of the chest, and falls.
A61B 5/0205 - Évaluation simultanée de l'état cardio-vasculaire et de l'état d'autres parties du corps, p. ex. de l'état cardiaque et respiratoire
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/02 - Détection, mesure ou enregistrement en vue de l'évaluation du système cardio-vasculaire, p. ex. mesure du pouls, du rythme cardiaque, de la pression sanguine ou du débit sanguin
A61B 5/1455 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des capteurs optiques, p. ex. des oxymètres à photométrie spectrale
A medical device data back-association system, apparatuses, and methods are disclosed. In an example embodiment, an electronic medical record memory receives, while an infusion pump is administering a medication to a patient, an identifier message including at least two of a device identifier of the infusion pump, a patient identifier of the patient, and a medication order identifier of a medication being administer by the infusion pump. The memory creates an association between an electronic medical record (“EMR”) of the patient and the infusion pump using the identifier message. The memory next receives, after the association between the EMR of the patient and the infusion pump, infusion pump data from the infusion pump. The infusion pump data includes the device identifier. The memory then stores the infusion pump data to the EMR of the patient based on the created association between the EMR of the patient and the infusion pump.
G16H 10/60 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données spécifiques de patients, p. ex. pour des dossiers électroniques de patients
G16H 20/17 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients administrés par perfusion ou injection
G16H 40/60 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux
100.
SYSTEMS AND METHODS FOR CONTROLLING PARTIAL DELIVERY PUMPING IN INFUSION SYSTEMS
A method and system for delivering partial boluses using infusion pumps is disclosed. An example method includes storing a programmed dose volume to be administered in response to a request from a patient and instructing the pump to begin dispensing the programmed dose volume of fluid from the fluid supply. The method further includes receiving an indication that the pump has stopped pumping, determining a partial dose volume, and when the partial dose volume equals a value greater than zero, generate an alarm that the fluid supply is depleted. Additionally, the method includes exchanging the depleted fluid supply with a subsequent fluid supply, dispensing from the subsequent fluid supply the partial dose volume, and preventing any subsequent dispensing of fluid from the subsequent fluid supply for a programed lockout period.
